{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:30:47Z","timestamp":1778815847018,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.seizure.2022.09.017","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T02:25:08Z","timestamp":1664159108000},"page":"74-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses"],"prefix":"10.1016","volume":"102","author":[{"given":"Puneet","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-8792","authenticated-orcid":false,"given":"Satinder","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-9718","authenticated-orcid":false,"given":"Ravindra","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3135-3306","authenticated-orcid":false,"given":"Suvasini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.seizure.2022.09.017_bib0001","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Leppik","year":"1983","journal-title":"JAMA"},{"issue":"Suppl 8","key":"10.1016\/j.seizure.2022.09.017_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","article-title":"RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics","volume":"52 Suppl 8","author":"Silbergleit","year":"2011","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.017_bib0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.017_bib0004","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamaneurol.2021.0520","article-title":"Association between treatment progression, disease refractoriness, and burden of illness among hospitalized patients with status epilepticus","volume":"78","author":"Guterman","year":"2021","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.seizure.2022.09.017_bib0005","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/epi.13837","article-title":"Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.017_bib0006","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41582-022-00664-3","article-title":"Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus","volume":"18","author":"Burman","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 12","key":"10.1016\/j.seizure.2022.09.017_bib0007","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1528-1167.2009.02368.x","article-title":"What is the relative value of the standard anticonvulsants: phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?","volume":"50","author":"Trinka","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2022.09.017_bib0008","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200022060-00004","article-title":"Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs","volume":"22","author":"DeToledo","year":"2000","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.seizure.2022.09.017_bib0009","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1586\/14737175.2015.1074523","article-title":"The safety and efficacy of fosphenytoin for the treatment of status epilepticus","volume":"15","author":"Pop\u0142awska","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.seizure.2022.09.017_bib0010","article-title":"Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis","author":"Abdelgadir","year":"2020","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmab014","article-title":"Efficacy and safety of levetiracetam vs. phenytoin as second line antiseizure medication for pediatric convulsive status epilepticus: a systematic review and meta-analysis of randomized controlled trials","volume":"67","author":"Angurana","year":"2021","journal-title":"J Trop Pediatr"},{"issue":"10231","key":"10.1016\/j.seizure.2022.09.017_bib0012","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.seizure.2022.09.017_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107286","article-title":"Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: a systematic review and meta-analysis","volume":"111","author":"DeMott","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.09.017_bib0014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.seizure.2021.07.012","article-title":"Efficacy and safety of levetiracetam versus (fos)phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials","volume":"91","author":"Feng","year":"2021","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.017_bib0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s13312-020-1755-4","article-title":"Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial","volume":"57","author":"Vignesh","year":"2020","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.seizure.2022.09.017_bib0016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2017.07.005","article-title":"Comparison of lacosamide versus sodium valproate in status epilepticus: a pilot study","volume":"76","author":"Misra","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.seizure.2022.09.017_bib0017","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2022.09.017_bib0018","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.seizure.2022.09.017_bib0019","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.seizure.2022.09.017_bib0020","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.017_bib0021","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.seizure.2022.09.017_bib0022","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fneur.2019.00506","article-title":"A comparison of parenteral phenobarbital vs. parenteral phenytoin as second-line management for pediatric convulsive status epilepticus in a resource-limited setting","volume":"10","author":"Burman","year":"2019","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.seizure.2022.09.017_bib0023","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","article-title":"Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study","volume":"18","author":"Chen","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.seizure.2022.09.017_bib0024","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2022.09.017_bib0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jocn.2014.12.013","article-title":"Levetiracetam versus phenytoin in management of status epilepticus","volume":"22","author":"Chakravarthi","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"10186","key":"10.1016\/j.seizure.2022.09.017_bib0026","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.017_bib0027","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/jpn.JPN_109_19","article-title":"Levetiracetam versus fosphenytoin in pediatric convulsive status epilepticus: a randomized controlled trial","volume":"15","author":"Handral","year":"2020","journal-title":"J Pediatr Neurosci"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.017_bib0028","first-page":"85","article-title":"Comparison of the effect of phenobarbital versus sodium valproate in management of children with status epilepticus","volume":"12","author":"Khajeh","year":"2018","journal-title":"Iran J Child Neurol"},{"issue":"10186","key":"10.1016\/j.seizure.2022.09.017_bib0029","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.seizure.2022.09.017_bib0030","article-title":"A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus","author":"Misra","year":"2017","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2022.09.017_bib0031","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12098-020-03221-2","article-title":"Clinical effectiveness of levetiracetam compared to fosphenytoin in the treatment of benzodiazepine refractory convulsive status epilepticus","volume":"87","author":"Nalisetty","year":"2020","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.017_bib0032","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3988\/jcn.2019.15.4.468","article-title":"Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the management of generalized convulsive status epilepticus in children: an open-label randomized controlled trial","volume":"15","author":"Noureen","year":"2019","journal-title":"J Clin Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.017_bib0033","doi-asserted-by":"crossref","first-page":"237","DOI":"10.17511\/ijpr.2018.i04.13","article-title":"Randomized controlled trial of levetiracetam versus fosphenytoin for convulsive status epilepticus in children","volume":"5","author":"Senthil Kumar","year":"2018","journal-title":"Int J Pediatr Res"},{"key":"10.1016\/j.seizure.2022.09.017_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106755","article-title":"Phenobarbital versus valproate for generalized convulsive status epilepticus in adults (2): a multicenter prospective randomized controlled trial in China (China 2-P vs. V)","volume":"177","author":"Su","year":"2021","journal-title":"Epilepsy Res."},{"issue":"12","key":"10.1016\/j.seizure.2022.09.017_bib0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40263-016-0388-6","article-title":"Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China","volume":"30","author":"Su","year":"2016","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.017_bib0036","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.seizure.2022.09.017_bib0037","first-page":"S216","article-title":"A comparative assessment the efficacy of intravenous infusion of sodium valproate and phenytion in the treatment of status epilepticus","volume":"4","author":"Chitsaz","year":"2013","journal-title":"Int J Prev Med"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.017_bib0038","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2022.09.017_bib0039","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2017.05.001","article-title":"Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: a prospective, randomized study","volume":"49","author":"Gujjar","year":"2017","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2022.09.017_bib0041","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.04.013","article-title":"Management of generalised convulsive status epilepticus (SE): a prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam\u2013Pilot study","volume":"114","author":"Mundlamuri","year":"2015","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0042","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14581\/jer.20011","article-title":"Comparative efficacy of IV phenytoin, IV valproate, and IV levetiracetam in childhood status epilepticus","volume":"10","author":"Nazir","year":"2020","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.seizure.2022.09.017_bib0043","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.seizure.2019.01.015","article-title":"Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): a prospective randomized controlled pilot study","volume":"65","author":"Nene","year":"2019","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0044","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.38.2.202","article-title":"Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin","volume":"38","author":"Shaner","year":"1988","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpn.2009.02.004","article-title":"Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial","volume":"14","author":"Sreenath","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"12","key":"10.1016\/j.seizure.2022.09.017_bib0046","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.seizure.2022.09.017_bib0047","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.4103\/jfmpc.jfmpc_750_19","article-title":"Levetiracetam versus phenytoin in children with status epilepticus","volume":"8","author":"Wani","year":"2019","journal-title":"J Family Med Prim Care"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0048","doi-asserted-by":"crossref","first-page":"741","DOI":"10.18203\/2349-3291.ijcp20190722","article-title":"Levetiracetam versus phenytoin for treatment of convulsive status epilepticus in pediatric population: a randomized controlled trial","volume":"6","author":"Pooja Sharma","year":"2019","journal-title":"Int J Contemp Pediatr"},{"issue":"2","key":"10.1016\/j.seizure.2022.09.017_bib0049","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/JPN.JPN_126_17","article-title":"IV Levetiracetam versus IV Phenytoin in childhood seizures: a randomized controlled trial","volume":"12","author":"Kanika Singh","year":"2018","journal-title":"J Pediaric Neurosci"},{"issue":"8","key":"10.1016\/j.seizure.2022.09.017_bib0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.arcped.2021.09.011","article-title":"Comparison of the effect of continuous intravenous infusion of sodium valproate and midazolam on management of status epilepticus in children","volume":"28","author":"Abbaskhanian","year":"2021","journal-title":"Arch Pediatr"},{"issue":"10","key":"10.1016\/j.seizure.2022.09.017_bib0051","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0883073807306248","article-title":"Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial","volume":"22","author":"Mehta","year":"2007","journal-title":"J. Child Neurol."},{"issue":"22","key":"10.1016\/j.seizure.2022.09.017_bib0052","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.seizure.2022.09.017_bib0053","doi-asserted-by":"crossref","first-page":"e00951","DOI":"10.1002\/brb3.951","article-title":"Sodium valproate compared to phenytoin in treatment of status epilepticus","volume":"8","author":"Amiri-Nikpour","year":"2018","journal-title":"Brain Behav"},{"issue":"6","key":"10.1016\/j.seizure.2022.09.017_bib0054","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ana.25249","article-title":"Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures","volume":"83","author":"Husain","year":"2018","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.017_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-020-00975-7","article-title":"Preferential antiseizure medications in pediatric patients with convulsive status epilepticus: a systematic review and network meta-analysis","volume":"41","author":"Zhang","year":"2021","journal-title":"Clin Drug Investig"},{"issue":"Pt B","key":"10.1016\/j.seizure.2022.09.017_bib0056","article-title":"Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: a systematic review and network meta-analysis","volume":"101","author":"Brigo","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2022.09.017_bib0057","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"3","key":"10.1016\/j.seizure.2022.09.017_bib0058","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13312-020-1753-6","article-title":"Clinical profile and short-term outcome of pediatric status epilepticus at a tertiary-care center in Northern India","volume":"57","author":"Chetan","year":"2020","journal-title":"Indian Pediatr"},{"issue":"10 Supplement","key":"10.1016\/j.seizure.2022.09.017_bib0059","article-title":"Etiology of pediatric refractory convulsive status epilepticus. Results from the pediatric status epilepticus research group (pSERG) (S29.005)","volume":"82","author":"Gaillard","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2022.09.017_bib0060","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2022.09.017_bib0061","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.seizure.2016.01.014","article-title":"Clinical profile and outcome of refractory convulsive status epilepticus in older children from a developing country","volume":"36","author":"Lingappa","year":"2016","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.seizure.2022.09.017_bib0062","first-page":"2597","article-title":"Very high dose phenobarbital for refractory status epilepticus","volume":"90","author":"Tiamkao","year":"2007","journal-title":"J Med Assoc Thai"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:02:14Z","timestamp":1761012134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122002151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":62,"alternative-id":["S1059131122002151"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.09.017","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}